Clinical Trials Directory

Trials / Completed

CompletedNCT03956732

Effects of Milk Protein and Vitamin D on Children's Growth and Health

Effects of Milk Protein and Vitamin D on Children's Growth and Health (D-pro)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
6 Years – 8 Years
Healthy volunteers
Accepted

Summary

The purpose of D-pro is to investigate the combined and separate effects of milk protein and vitamin D on bone health, growth, muscle function, body composition and cardiometabolic health in 6-8-year-old children.

Detailed description

The D-pro study investigates the effects of high or medium intakes of milk protein, and vitamin D supplements or placebo, in healthy 6-8 year-old Danish children. The study is a 2×2-factorial randomized controlled trial with 4 study arms. The subjects will be randomly allocated to receive yoghurt products with either high or medium protein content (300g/day, 6 days/week) and to receive tablets with either vitamin D (20 μg/day) or placebo for 24 weeks. Measurements and biological sampling will be performed at baseline and at the end of the intervention. The primary outcome will be bone mineral density (BMD). The investigators will also measure effects on children's muscle function, cardiometabolic health, body composition, growth and growth factors, nutrient status, immune defence and risk of acute respiratory tract infections, as well as appetite hormones. The investigators will also assess potential sex-specific effects and the potential modifying effect of genotype.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMilk Protein (high)High protein yoghurt which contains approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.
DIETARY_SUPPLEMENTVitamin DOne daily tablet containing 20 μg of vitamin D3, cholecalciferol.
DIETARY_SUPPLEMENTMilk Protein (medium)Ordinary yoghurt containing approx. 3.3 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.

Timeline

Start date
2019-06-20
Primary completion
2020-04-03
Completion
2020-04-03
First posted
2019-05-21
Last updated
2020-04-15

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03956732. Inclusion in this directory is not an endorsement.